0000899243-16-033097.txt : 20161109 0000899243-16-033097.hdr.sgml : 20161109 20161109202928 ACCESSION NUMBER: 0000899243-16-033097 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161107 FILED AS OF DATE: 20161109 DATE AS OF CHANGE: 20161109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BELANOFF JOSEPH K CENTRAL INDEX KEY: 0001286199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 161985650 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-11-07 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001286199 BELANOFF JOSEPH K C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 1 1 0 0 CHIEF EXECUTIVE OFFICER Common Stock 2016-11-07 4 M 0 93533 1.50 A 2257728 D Common Stock 2016-11-07 4 S 0 93533 8.2212 D 2164195 D Common Stock 2016-11-07 4 M 0 406467 1.50 A 2570662 D Common Stock 2016-11-07 4 S 0 406467 8.3244 D 2164195 D Stock Option (Right to Buy) 1.50 2016-11-07 4 M 0 93533 0.00 D 2017-04-16 Common Stock 93533 906467 D Stock Option (Right to Buy) 1.50 2016-11-07 4 M 0 406467 0.00 D 2017-04-16 Common Stock 406467 500000 D Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.22 to $8.24 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.27 to $8.375 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request. Fully exercisable. /s/ Charles Robb, Attorney-in-Fact for Joseph K. Belanoff 2016-11-09